Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Protein farnesyltransferase inhibitors patented by Pfizer for cancer

Jan. 27, 1998

Resistance modulators for use in cancer and malaria developed at Lilly

Jan. 27, 1998

Theratechnologies' novel cancer treatment granted additional patent protection

Jan. 26, 1998

Imidazoles for reversing MDR prepared at Ontogen

Jan. 26, 1998

Clinical results reported for Servier's MDR-reversing agent S-9788

Jan. 23, 1998

Ontogen describes novel MDR modulators

Jan. 23, 1998

Merck & Co. describes FPTase inhibitors with improved pharmacokinetics

Jan. 23, 1998

New telomerase inhibitors from Geron

Jan. 23, 1998

Princeton and Lilly collaborate on development of inhibitors of folate enzymes

Jan. 23, 1998

Gastrimmune significantly increases survival in advanced colorectal cancer

Jan. 22, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 12, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...